Posted by Michael Wonder on 28 Jun 2022
Monkeypox: EMA starts review for Imvanex
28 June 2022 - The EMA’s CHMP has started a review of data to extend the use of the smallpox vaccine Imvanex to include protecting people from monkeypox disease.
Imvanex is currently authorised in the EU for the prevention of smallpox in adults.
